BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
KLK3
,
calcium channel activity
,
Leukemia
,
Breast
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Kinesin-like protein
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Hippocampus
Dorsal root ganglia
Testes
Midbrain
Cerebral cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Social environment related disease
Vesicular stomatitis Indiana virus disease
Severe acute respiratory syndrome
Viral disease
Effect of exposure to physical force
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Faslodex
LTBR protein, human
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane
Ceramides
PTC-209
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PRC1
NRF1
GPR17
COL7A1
WTAP
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Bone marrow derived macrophages infected with H. pylori
The Immunological Genome Project - Immune cell lineage differentiation and maturation
Fibroblast IMR-90 cells treated with gamma-radiation
Myeloid-derived suppressor splenocytes from mice with or without esophageal tumors
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Kinesin-like protein
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Additional KIF6 Risk Offers Better Adherence to Statins
Nutrition and Physical Activity in Patients With Cerebrovascular Disease
A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
Pembrolizumab (MK-3475) in MM Patients With Residual Disease
Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ